Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti--Methyl--Aspartate Receptor Encephalitis: First Case Report

Anti- N -methyl- d -aspartate (NMDA) receptor encephalitis is caused by altered patient immune reactions. This study reports the first patient with severe neurologic sequelae after NMDA receptor encephalitis treated with allogeneic umbilical cord–derived mesenchymal stem/stromal cells (UC-MSCs). A 5...

Full description

Bibliographic Details
Main Authors: Liem Nguyen Thanh, Van T. Hoang, Huong Le Thu, Phuong Anh Thi Nguyen, Duc M. Hoang, Doan Van Ngo, Hung Cao Vu, Van Nguyen Thi Bich, Michael Heke
Format: Article
Language:English
Published: SAGE Publishing 2022-07-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/09636897221110876
_version_ 1818488919903174656
author Liem Nguyen Thanh
Van T. Hoang
Huong Le Thu
Phuong Anh Thi Nguyen
Duc M. Hoang
Doan Van Ngo
Hung Cao Vu
Van Nguyen Thi Bich
Michael Heke
author_facet Liem Nguyen Thanh
Van T. Hoang
Huong Le Thu
Phuong Anh Thi Nguyen
Duc M. Hoang
Doan Van Ngo
Hung Cao Vu
Van Nguyen Thi Bich
Michael Heke
author_sort Liem Nguyen Thanh
collection DOAJ
description Anti- N -methyl- d -aspartate (NMDA) receptor encephalitis is caused by altered patient immune reactions. This study reports the first patient with severe neurologic sequelae after NMDA receptor encephalitis treated with allogeneic umbilical cord–derived mesenchymal stem/stromal cells (UC-MSCs). A 5-year-old girl was diagnosed with NMDA receptor encephalitis and treated with immunosuppressive medicaments and intravenous immunoglobulin (IVIG). Despite intensive therapy, the patient’s condition worsened so that allogenic UC-MSC therapy was contemplated. The patient received three intrathecal infusions of xeno- and serum-free cultured UC-MSCs at a dose of 10 6 cells/kg. At baseline and after each UC-MSC administration, the patient was examined by the German Coma Recovery Scale (CRS), the Gross Motor Function Classification System (GMFCS), the Gross Motor Function Measure–88 (GMFM-88), the Manual Ability Classification System (MACS), the Modified Ashworth Scale, and the Denver II test. Before cell therapy, she was in a permanent vegetative state with diffuse cerebral atrophy. Her cognition and motor functions improved progressively after three UC-MSC infusions. At the last visit, she was capable of walking, writing, and counting numbers. Control of urinary and bowel functions was completely recovered. Cerebral atrophy was reduced on brain magnetic resonance imaging (MRI). Overall, the outcomes of this patient suggest a potential cell therapy for autoimmune encephalitis and its neurological consequences.
first_indexed 2024-12-10T16:57:18Z
format Article
id doaj.art-bd6e645e65b84d0eb274b43f6f5071ab
institution Directory Open Access Journal
issn 1555-3892
language English
last_indexed 2024-12-10T16:57:18Z
publishDate 2022-07-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-bd6e645e65b84d0eb274b43f6f5071ab2022-12-22T01:40:41ZengSAGE PublishingCell Transplantation1555-38922022-07-013110.1177/09636897221110876Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti--Methyl--Aspartate Receptor Encephalitis: First Case ReportLiem Nguyen Thanh0Van T. Hoang1Huong Le Thu2Phuong Anh Thi Nguyen3Duc M. Hoang4Doan Van Ngo5Hung Cao Vu6Van Nguyen Thi Bich7Michael Heke8College of Health Science, VinUniversity, Hanoi, VietnamVinmec Research Institute of Stem Cell and Gene Technology, Vinmec Health Care System, Hanoi, VietnamVinmec International Hospital, Hanoi, VietnamVinmec International Hospital, Hanoi, VietnamVinmec Research Institute of Stem Cell and Gene Technology, Vinmec Health Care System, Hanoi, VietnamVinmec International Hospital, Hanoi, VietnamVietnam National Children’s Hospital, Hanoi, VietnamVietnam National Children’s Hospital, Hanoi, VietnamDepartment of Biology, Stanford University, Stanford, CA, USAAnti- N -methyl- d -aspartate (NMDA) receptor encephalitis is caused by altered patient immune reactions. This study reports the first patient with severe neurologic sequelae after NMDA receptor encephalitis treated with allogeneic umbilical cord–derived mesenchymal stem/stromal cells (UC-MSCs). A 5-year-old girl was diagnosed with NMDA receptor encephalitis and treated with immunosuppressive medicaments and intravenous immunoglobulin (IVIG). Despite intensive therapy, the patient’s condition worsened so that allogenic UC-MSC therapy was contemplated. The patient received three intrathecal infusions of xeno- and serum-free cultured UC-MSCs at a dose of 10 6 cells/kg. At baseline and after each UC-MSC administration, the patient was examined by the German Coma Recovery Scale (CRS), the Gross Motor Function Classification System (GMFCS), the Gross Motor Function Measure–88 (GMFM-88), the Manual Ability Classification System (MACS), the Modified Ashworth Scale, and the Denver II test. Before cell therapy, she was in a permanent vegetative state with diffuse cerebral atrophy. Her cognition and motor functions improved progressively after three UC-MSC infusions. At the last visit, she was capable of walking, writing, and counting numbers. Control of urinary and bowel functions was completely recovered. Cerebral atrophy was reduced on brain magnetic resonance imaging (MRI). Overall, the outcomes of this patient suggest a potential cell therapy for autoimmune encephalitis and its neurological consequences.https://doi.org/10.1177/09636897221110876
spellingShingle Liem Nguyen Thanh
Van T. Hoang
Huong Le Thu
Phuong Anh Thi Nguyen
Duc M. Hoang
Doan Van Ngo
Hung Cao Vu
Van Nguyen Thi Bich
Michael Heke
Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti--Methyl--Aspartate Receptor Encephalitis: First Case Report
Cell Transplantation
title Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti--Methyl--Aspartate Receptor Encephalitis: First Case Report
title_full Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti--Methyl--Aspartate Receptor Encephalitis: First Case Report
title_fullStr Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti--Methyl--Aspartate Receptor Encephalitis: First Case Report
title_full_unstemmed Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti--Methyl--Aspartate Receptor Encephalitis: First Case Report
title_short Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti--Methyl--Aspartate Receptor Encephalitis: First Case Report
title_sort human umbilical cord mesenchymal stem cells for severe neurological sequelae due to anti methyl aspartate receptor encephalitis first case report
url https://doi.org/10.1177/09636897221110876
work_keys_str_mv AT liemnguyenthanh humanumbilicalcordmesenchymalstemcellsforsevereneurologicalsequelaeduetoantimethylaspartatereceptorencephalitisfirstcasereport
AT vanthoang humanumbilicalcordmesenchymalstemcellsforsevereneurologicalsequelaeduetoantimethylaspartatereceptorencephalitisfirstcasereport
AT huonglethu humanumbilicalcordmesenchymalstemcellsforsevereneurologicalsequelaeduetoantimethylaspartatereceptorencephalitisfirstcasereport
AT phuonganhthinguyen humanumbilicalcordmesenchymalstemcellsforsevereneurologicalsequelaeduetoantimethylaspartatereceptorencephalitisfirstcasereport
AT ducmhoang humanumbilicalcordmesenchymalstemcellsforsevereneurologicalsequelaeduetoantimethylaspartatereceptorencephalitisfirstcasereport
AT doanvanngo humanumbilicalcordmesenchymalstemcellsforsevereneurologicalsequelaeduetoantimethylaspartatereceptorencephalitisfirstcasereport
AT hungcaovu humanumbilicalcordmesenchymalstemcellsforsevereneurologicalsequelaeduetoantimethylaspartatereceptorencephalitisfirstcasereport
AT vannguyenthibich humanumbilicalcordmesenchymalstemcellsforsevereneurologicalsequelaeduetoantimethylaspartatereceptorencephalitisfirstcasereport
AT michaelheke humanumbilicalcordmesenchymalstemcellsforsevereneurologicalsequelaeduetoantimethylaspartatereceptorencephalitisfirstcasereport